Compare IVVD & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVVD | IPI |
|---|---|---|
| Founded | 2020 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 437.1M | 380.0M |
| IPO Year | 2021 | 2007 |
| Metric | IVVD | IPI |
|---|---|---|
| Price | $1.61 | $37.48 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 5 | 1 |
| Target Price | $8.75 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 3.6M | 416.4K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 79.02 | ★ 105.14 |
| EPS | N/A | ★ 0.85 |
| Revenue | $53,426,000.00 | ★ $298,328,000.00 |
| Revenue This Year | $147.67 | $5.01 |
| Revenue Next Year | $22.76 | N/A |
| P/E Ratio | ★ N/A | $44.66 |
| Revenue Growth | ★ 110.47 | 17.13 |
| 52 Week Low | $0.46 | $22.55 |
| 52 Week High | $3.07 | $50.34 |
| Indicator | IVVD | IPI |
|---|---|---|
| Relative Strength Index (RSI) | 53.06 | 43.46 |
| Support Level | $1.41 | $37.00 |
| Resistance Level | $1.77 | $49.06 |
| Average True Range (ATR) | 0.15 | 3.14 |
| MACD | 0.05 | -0.92 |
| Stochastic Oscillator | 71.43 | 6.55 |
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.